Medico Remedies Limited (NSE:MEDICO)

India flag India · Delayed Price · Currency is INR
69.60
-0.33 (-0.47%)
Feb 12, 2025, 3:29 PM IST
-15.38%
Market Cap 5.52B
Revenue (ttm) 1.51B
Net Income (ttm) 88.52M
Shares Out n/a
EPS (ttm) 1.06
PE Ratio 62.34
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,632,134
Average Volume 1,914,503
Open 70.00
Previous Close 69.93
Day's Range 67.71 - 71.44
52-Week Range 34.80 - 90.00
Beta 0.16
RSI 41.52
Earnings Date Feb 7, 2025

About Medico Remedies

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster... [Read more]

Sector Healthcare
Founded 1994
Employees 193
Stock Exchange National Stock Exchange of India
Ticker Symbol MEDICO
Full Company Profile

Financial Performance

In 2023, Medico Remedies's revenue was 1.45 billion, an increase of 3.19% compared to the previous year's 1.40 billion. Earnings were 82.91 million, an increase of 14.49%.

Financial Statements

News

There is no news available yet.